pargyline
Trade name: eutonyl
Small moleculeapproved
Pargyline is an irreversible selective monoamine oxidase (MAO)-B inhibitor, which possesses higher selectivity to this isoform in comparison with MAO-A. It was approved under brand name eutonyl for the treatment hypertension, but then this drug was discontinued. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
Indications
Approved for
Mechanism of action
- Monoamine oxidaseINHIBITOR
Monoamine oxidase inhibitor
Combination products
eutron
with methyclothiazide
Approval history
- approved—
Chemistry & pharmacology
Loading structure…
SMILES
C#CCN(C)Cc1ccccc1- Mol. weight
- 159.23 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL673 ↗
- WikipediaPargyline ↗
- NCATSW70V6I2OMY ↗
- ChEMBLCHEMBL1200425 ↗
Also known as
- a-19120
- a-19120
- eutonyl
- eutonyl
- eutonyl
- eutonyl
- eutonyl
- eutron
- eutron
- eutron
- mo-911
- mo-911
- n-methyl-n-benzylpropynylamine
- pargylamine
- pargylin
- pargyline
- pargyline
- pargyline
- pargyline
- pargyline
- pargyline
- pargyline
- pargyline
- pargyline
- pargyline hcl
- pargyline hcl
- pargyline hcl
- pargyline hydrochloride
- pargyline hydrochloride
- pargyline hydrochloride
- pargyline hydrochloride
- pargyline hydrochloride
- pargyline hydrochloride
- pargyline hydrochloride
- supirdyl
Organizations
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Abbott | For profit | NDA | Jun 28, 1966 |